Search

Search Constraints

You searched for: Author/Creator Casper, Keith

Search Results

1. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020)

2. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020)

4. Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma. (December 2020)

5. Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials. (March 2022)

6. Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation. (October 2021)

7. Modified Head and Neck Swallow Scale: Using EORTC‐QLQ‐H&N35 to Predict Overall Survival. (24th April 2021)

8. Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin. Issue 8 (27th January 2020)

9. Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal Cancer. (29th April 2021)

10. Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV‐Related Oropharyngeal Cancer. (29th April 2021)